Traction method versus conventional endoscopic submucosal dissection for gastric epithelial neoplasms: A randomized controlled trial.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
01 Apr 2022
Historique:
received: 07 03 2022
accepted: 08 03 2022
entrez: 14 4 2022
pubmed: 15 4 2022
medline: 19 4 2022
Statut: ppublish

Résumé

Endoscopic submucosal dissection (ESD) is an advanced therapeutic technique for en bloc resection of superficial gastrointestinal neoplasms. Although gastric ESD is minimally invasive and provides favorable outcomes, it is technically difficult and requires a long procedure time for dissection. The traction-assisted approach overcomes some of the difficulties of gastric ESD, but its ability to reduce the procedure time remains unclear. The traction-assisted approach using dental floss and a clip did not reduce procedure time in the total population, but it reduced procedure time for lesions limited to the greater curvature of the upper or middle of the stomach. Although the traction direction of the clip-with-line method may be limited to the oral side via the cardia, EndoTrac ESD may provide flexible traction at any time during the procedure. This prospective randomized control study has been designed to compare the efficacy and safety of EndoTrac and conventional gastric ESD. This multicenter, randomized control trial will enroll 150 patients at 2 hospitals in Japan undergoing EndoTrac or conventional ESD for gastric epithelial neoplasia. Patients with a single gastric epithelial neoplasm who meet the inclusion and exclusion criteria will be randomized to EndoTrac or conventional ESD. Patients will be randomized by a computer-generated random sequence with stratification by operator experience, tumor size, tumor location, and institution. The primary endpoint will be ESD procedure time, defined as the time from the start of the submucosal injection to the completion of resection. Other outcomes will include the rates of adverse events and pathological curability. The ability of EndoTrac ESD to reduce the long procedure time and/or adverse events observed with conventional ESD can not only reduce physical stress on the patient, but can also reduce length of hospital stay and medical costs. Reduced technical difficulty will contribute to the widespread adoption of this ESD technique worldwide. University Hospital Medial Information Network Clinical Trials Registry (UMIN-CTR), ID: 000044450; Registered on June 6, 2021.https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000050485. 1.1, March 1, 2022. Patient enrolment began on June 6, 2021 and is expected to be completed by July 19, 2025.

Identifiants

pubmed: 35421071
doi: 10.1097/MD.0000000000029172
pii: 00005792-202204010-00015
pmc: PMC9276441
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29172

Informations de copyright

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Isomoto H, Shikuwa S, Yamaguchi N, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut 2009;58:331–6.
Chung IK, Lee JH, Lee SH, et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc 2009;69:1228–35.
Pyo JH, Lee H, Min BH, et al. Long-term outcome of endoscopic resection vs. surgery for early gastric cancer: a non-inferiority-matched cohort study. Am J Gastroenterol 2016;111:240–9.
Gotoda T, Yamamoto H, Soetikno R. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol 2006;41:929–42.
Choi KS, Jung HY, Choi KS, et al. EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointest Endosc 2011;73:942–8.
Gotoda T, Yang HK. The desired balance between treatment and curability in treatment planning for early gastric cancer. Gastrointest Endosc 2015;82:308–10.
Imagawa A, Okada H, Kawahara Y, et al. Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success. Endoscopy 2006;38:987–90.
Nagata S, Jin YF, Tomoeda M, et al. Influential factors in procedure time of endoscopic submucosal dissection for gastric cancer with fibrotic change. Dig Endosc 2011;23:296–301.
Kondo H, Gotoda T, Ono H, et al. Percutaneous traction-assisted EMR by using an insulation-tipped electrosurgical knife for early stage gastric cancer. Gastrointest Endosc 2004;59:284–8.
Kobayashi T, Gotohda T, Tamakawa K, Ueda H, Kakizoe T. Magnetic anchor for more effective endoscopic mucosal resection. Jpn J Clin Oncol 2004;34:118–23.
Imaeda H, Iwao Y, Ogata H, et al. A new technique for endoscopic submucosal dissection for early gastric cancer using an external grasping forceps. Endoscopy 2006;38:1007–10.
Hijikata Y, Ogasawara N, Sasaki M, et al. Endoscopic submucosal dissection with sheath-assisted counter traction for early gastric cancers. Dig Endosc 2010;22:124–8.
Ueki M, Ikebuchi Y, Matsuoka H, et al. Endoscopic submucosal dissection assisted by novel “clip fishing method” (with video). Endoscopy 2010;42 (Suppl 2):E277–8.
Imaeda H, Hosoe N, Kashiwagi K, et al. Advanced endoscopic submucosal dissection with traction. World J Gastrointest Endosc 2014;6:286–95.
Oyama T. Counter traction makes endoscopic submucosal dissection easier. Clin Endosc 2012;45:375–8.
Fukami N. What we want for ESD is a second hand! Traction method. Gastrointest Endosc 2013;78:274–6.
Yoshida M, Takizawa K, Suzuki S, et al. Conventional versus traction-assisted endoscopic submucosal dissection for gastric neoplasms: a multicenter, randomized controlled trial (with video). Gastrointest Endosc 2018;87:1231–40.
Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2018. 5th ed. Gastric Cancer; 2021:24:1–21.
Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc 2014;26:1–14.
Choi IJ, Kim CG, Chang HJ, Kim SG, Kook MC, Bae JM. The learning curve for EMR with circumferential mucosal incision in treating intramucosal gastric neoplasm. Gastrointest Endosc 2005;62:860–5.
Ono S, Kato M, Nakagawa M, Imai A, Yamamoto K, Shimizu Y. Outcomes and predictive factors of “not self-completion” in gastric endoscopic submucosal dissection for novice operators. Surg Endosc 2013;27:3577–83.
Tsuji Y, Ohata K, Sekiguchi M, et al. An effective training system for endoscopic submucosal dissection of gastric neoplasm. Endoscopy 2011;43:1033–8.
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101–12.
Mochizuki S, Uedo N, Oda I, et al. Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial): a multicentre prospective randomised controlled non-inferiority trial. Gut 2015;64:397–405.
Suzuki S, Gotoda T, Kobayashi Y, et al. Usefulness of a traction method using dental floss and a hemoclip for gastric endoscopic submucosal dissection: a propensity score matching analysis (with videos). Gastrointest Endosc 2016;83:337–46.
Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events report of an ASGE workshop. Gastrointest Endosc 2010;71:446–54.
Sakaguchi H, Toyonaga T, Kaku H, et al. The crane technique: a novel traction method for use during rectal endoscopic submucosal dissection. Endoscopy 2019;51:E88–9. (abstract).

Auteurs

Jun Kinoshita (J)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Mikitaka Iguchi (M)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Takao Maekita (T)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Ke Wan (K)

Clinical Support Center, Wakayama Medical University, Wakayama, Japan.

Toshio Shimokawa (T)

Clinical Support Center, Wakayama Medical University, Wakayama, Japan.

Kazuhiro Fukatsu (K)

Department of Gastroenterology, Wakayama Rousai Hospital, Wakayama, Japan.

Daisaku Ito (D)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Shinya Taki (S)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Masayuki Nishimoto (M)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Masaki Takao (M)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Yasuto Tabata (Y)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Yousuke Mukai (Y)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Masayuki Kitano (M)

Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH